Overview

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Status:
Withdrawn
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
Study to determine drug interactions between GW273225 and the anticonvulsants valproate, carbamazepine or phenytoin
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline